Endurance Techn emerged as a top gainer in today's session of the NIFTY MIDCAP 150. According to the latest market data, the top gainers in NIFTY MIDCAP 150 include Endurance Techn at Rs 2,354.00 (6.25%), Solar Ind at Rs 14,185.00 (5.16%), GlaxoSmithKline at Rs 2,923.30 (4.91%), Gland at Rs 1,564.10 (4.39%), and Motilal Oswal at Rs 795.00 (4.34%).
The NIFTY MIDCAP 150 index saw Endurance Techn, Solar Ind, GlaxoSmithKline, Gland, and Motilal Oswal among the top gainers during today's trading session. This performance reflects notable movements within the midcap segment, showcasing varying degrees of positive momentum among key players.
Financial Performance Snapshot
A review of the financial performance of these companies offers insights into their recent operational and financial health. Here’s a summary of key financial indicators:
| Company | Revenue (Mar 2025) | Net Profit (Mar 2025) | EPS (Mar 2025) |
|---|---|---|---|
| Endurance Technologies | Rs 2,166.55 Cr | Rs 348.69 Cr | Rs 35.61 |
| Solar Industries | Rs 1,030.35 Cr | Rs 290.00 Cr | Rs 17.60 |
| GlaxoSmithKline | Rs 1,190.26 Cr | Rs -63.19 Cr | Rs -1.08 |
Endurance Technologies Financials
Endurance Technologies has demonstrated consistent financial performance over the past few quarters. The revenue has increased steadily, reaching Rs 2,166.55 Cr in March 2025 from Rs 1,610.71 Cr in March 2024. Similarly, the net profit has risen from Rs 240.15 Cr in March 2024 to Rs 348.69 Cr in March 2025. The EPS also shows an upward trend, increasing from Rs 25.98 to Rs 35.61 over the same period.
Solar Industries Financials
Solar Industries has also shown positive financial results. The revenue has grown from Rs 929.80 Cr in March 2024 to Rs 974.37 Cr in March 2025. The net profit has increased from Rs 194.48 Cr to Rs 262.87 Cr, and the EPS has risen from Rs 11.37 to Rs 15.52 over the same period.
GlaxoSmithKline Financials
In contrast, GlaxoSmithKline's financials reveal a different trajectory. While the revenue was Rs 1,174.83 Cr in March 2024, it decreased to Rs 1,030.35 Cr in March 2025. The net profit has declined from Rs 321.41 Cr to Rs 290.00 Cr, and the EPS has decreased from Rs 19.51 to Rs 17.60 over the same period.
Endurance Techn, Solar Ind, GlaxoSmithKline, Gland, and Motilal Oswal marked their presence among the top gainers in the NIFTY MIDCAP 150 during today's session.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
